Status:

COMPLETED

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Lead Sponsor:

Tactile Medical

Collaborating Sponsors:

Vanderbilt University Medical Center

Conditions:

Lymphedema

Lymphedema of Face

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To compare the effectiveness of an APCD to Usual Care in the management of lymphedema and fibrosis (LEF) in head and neck cancer (HNC) survivors.

Detailed Description

Aim 1: To compare the short-term and long-term effectiveness of self-administered APCD therapy versus Usual Care in HNC survivors with treatment naive LEF on anatomical measures of internal and exter...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Pathologically confirmed cancer of the HNC (larynx, pharynx, oral cavity, paranasal sinuses, major salivary glands, and HNC of unknown primary)
  • Completed curative intent cancer therapy with no evidence of active cancer at time of study enrollment
  • A diagnosis of either internal or external head and neck lymphedema
  • At least one core lymphedema associated symptom of ≥ 4 out of 10 at the time of study screening
  • Must be able and willing to participate in all aspects of the study and provide informed consent prior to study participation
  • Must be able to speak and understand English

Exclusion

  • Previous APCD or Usual Care treatment for HNC LEF
  • Acute facial infection (e.g., facial or parotid gland abscess)
  • Known carotid sinus hypersensitivity syndrome
  • Symptomatic carotid artery disease, as manifested by a recent transient ischemic attack (within 30 days), ischemic stroke, or amaurosis fugax (monocular visual ischemic symptoms or blindness)
  • Internal jugular venous thrombosis (within 3 months)
  • Patient is pregnant or trying to become pregnant

Key Trial Info

Start Date :

September 23 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2025

Estimated Enrollment :

236 Patients enrolled

Trial Details

Trial ID

NCT04797390

Start Date

September 23 2021

End Date

March 31 2025

Last Update

June 8 2025

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University of Alabama

Birmingham, Alabama, United States, 35924

2

Rush University Medical Center

Chicago, Illinois, United States, 60612

3

University of Louisville

Louisville, Kentucky, United States, 40202

4

Johns Hopkins University

Baltimore, Maryland, United States, 21205